Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer History

Cancer Prevention: Lowering your Risk

Cancer Screening Considerations: Balancing the Benefits and Risks

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer Pain Management

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

The Cancer Cell Surface Proteome as a Therapeutic Target

What Causes Cancer?

Effects of Social and Economic Deprivation on Cancer Mortality

Acidosis and Tumor Progression

See more featured articles »

Investigating the Molecular Mechanisms of Cancer

Secondary Lung Cancer

Cutaneous Manifestations of Internal Malignancy

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Overview of Cell Viability and Cytotoxicity

Secondary Brain Cancer

CDK9 and Cancer

Cancer Management

Caring for a Loved One with Cancer

Using Biomarkers to Detect Cancer

Metastatic Migration in Cancer may be Influenced by Metabolism

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Living with Cancer Pain

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer Glossary

What is Cancer of Unknown Primary?

Cancer Diagnosis

Extracellular Vesicles as Floating Cancer Biomarkers

The Biochemistry of Breast Cancer Screening

Assay for Monitoring and Treating Malignant Brain Tumors

Hypoxia Markers and Their Importance

Cancer Pathophysiology

Why are Cancer Cell Lines Useful?

What Role do Biobanks Play in Cancer Research?

What is Merkel Cell Carcinoma?

Cancer Classification

What is the Tumor Microenvironment?

The Effects of Cancer on Family Life

Targeted Cancer Therapies

TARDIS: The Improved Method of Detecting Breast Cancer

Pediatric Cancer

Insight into Cancer Vaccines

Cancer Epidemiology

Transforming Cancer Care through Genomic Testing

Myc Mutations and Cancer

Cancer Research

Insights into Oncofertility

What is Immunochemotherapy?

Cancer Pain

British Pioneers in Cancer Biology

Cancer Prognosis

Cancer Symptoms

Hot vs Cold: the differences between tumor types

What is Tumorigenesis?

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

What is Cancer?

Is Cancer a Metabolic Disorder?

Microfluidic cancer treatment screen combined with flow cytometry

Latest Cancer News and Research

Dr. Dan Landau receives Lotus Award for ovarian cancer research

Dr. Dan Landau, the Bibliowicz Family Professor of Medicine, and a member of the Sandra and Edward Meyer Cancer Center and the Englander Institute for Precision Medicine at Weill Cornell Medicine, has received a Lotus Award from the Pershing Square Foundation for research aimed at uncovering new immunotherapy targets in ovarian cancer.

15 Jun 2026

Engineered silica nanoparticles destroy prostate tumors in preclinical study

Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while enhancing anti-tumor immunity, according to a preclinical study led by investigators at Weill Cornell Medicine and the Cornell College of Engineering.

15 Jun 2026

Blocking a specific protein improves CAR T-cell therapy success in patients with blood cancers

University of Maryland School of Medicine (UMSOM) Researchers have identified a target that may improve the response of CAR T-cell therapy, a treatment for patients with recurrent or difficult to treat blood cancers.

15 Jun 2026

Neutrophils reduce the effectiveness of cancer immunotherapy in mice

A type of white blood cell in the immune system, known as neutrophils, can make cancer immunotherapy less effective. This is shown in a new study from Karolinska Institutet published in the journal Immunity.

15 Jun 2026

Tumor microenvironment drives drug resistance in lung cancer subtypes

A study by the University of Barcelona has discovered why the two main types of lung cancer — adenocarcinoma of the lung and squamous cell carcinoma — respond differently to anti-angiogenic therapy, that is, drugs that block the formation of new blood vessels that tumors need in order to grow.

15 Jun 2026

Massive study maps national medicine trends and health inequalities

The team from the BHF Data Science Centre at Health Data Research UK and the University of Liverpool say this type of analysis can offer opportunities for smarter and safer prescribing in their study published in the journal Nature Health.

15 Jun 2026

Dual-target CAR T therapy triggers broad immune response in brain cancer

Dual-target CAR T cell therapy for recurrent glioblastoma (GBM), delivered directly into the cerebrospinal fluid (CSF), triggers a broad immune response, with natural killer (NK) cell activation linked to better patient outcomes and longer overall survival.

15 Jun 2026

Targeted reminders increase serious illness conversations in cancer care

New research in the June 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that small, targeted prompts delivered to both patients and providers at the right moment can significantly increase the number of serious illness conversations that take place.

15 Jun 2026

Light-controlled molecular switch wakes lung cancer cells for treatment

Researchers from ETH Zurich have developed a molecular switch that is controlled by light. It wakes lung cancer cells up from a protective dormant state so that they are more accessible for treatment.

15 Jun 2026

Novel analysis identifies unique proliferation gene alterations in diverse cancer patients

New research to be presented today (Monday) at the annual conference of the European Society of Human Genetics shows that a cancer patient's genetic ancestry can have a significant effect both on how their disease progresses and their survival. In the largest study of its kind, researchers examined nearly 1,900 specific genetic changes in tumors in order to measure whether certain mutations were more common in patients with different historic geographic origins.

15 Jun 2026

Longer hormone exposure may increase thyroid cancer risk in women

Longer lifetime exposure to female hormones may increase the risk of thyroid cancer in women, according to a study being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

14 Jun 2026

Study finds gaps in guideline-based testosterone prescribing practices

Only a small number of men who were prescribed testosterone therapy received appropriate, guideline-concordant diagnostic testing, according to a study being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill, by Sophia Sinha, M.D., clinical assistant professor at the University of Michigan in Ann Arbor, Mich.

14 Jun 2026

Researchers identify vulnerabilities shared by surviving cancer cells

Cancer drugs can shrink fast-growing tumors. But sometimes a few tumor cells survive. These "persister" cells seed new tumors, forcing cancer patients into arduous cycles of testing and treatment.

12 Jun 2026

FDA approves new adjuvant treatment option for ccRCC patients with recurrence risk

The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2α inhibitor, as adjuvant treatment for adult patients with renal cell carcinoma with a clear cell component (ccRCC) at intermediate-high or high risk of recurrence following nephrectomy, with or without resection of metastatic lesions.

12 Jun 2026

Renowned physician‑scientist to lead Houston Methodist's cell and gene therapy research

Malcolm Brenner, an internationally recognized physician‑scientist renowned for his leadership in cell and gene therapy, has been tapped to lead the newly formed Houston Methodist Center for Cell and Gene Therapy.

12 Jun 2026

Major NIH grant helps establish the Oklahoma Center of ImmunoEngineering

The University of Oklahoma has received an $11.5 million award from the National Institutes of Health to establish the Oklahoma Center of ImmunoEngineering, a new research center designed to accelerate the study and treatment of diseases rooted in the immune system.

12 Jun 2026

Cellular process discovery may lead to new cancer treatments

A molecular geneticist at Montana State University has discovered a cellular process once believed impossible by scientists – the creation of the amino acid cysteine within a living cell when the cell's primary systems to do so fail. The discovery may one day lead to new cancer treatments.

12 Jun 2026

Novel metal-free prodrug suppresses cancer spread in preclinical models

A carefully designed metal-free carbon monoxide prodrug may help prevent some of the deadliest forms of cancer from spreading, according to researchers at Weill Cornell Medicine.

12 Jun 2026

New poll reveals political divide over public water fluoridation

As the debate over the value of adding fluoride to public drinking water percolates in communities across the nation, a new nationally representative survey from the Annenberg Public Policy Center (APPC) of the University of Pennsylvania finds Americans sharply divided over the use of fluoride in public drinking water.

12 Jun 2026